Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Gregory Arnsdorff, Nefertiti Greene, Brian Miller, Rick Brajer, Stephen Stamp

Premium

AdvaMedDx, a division of the Advanced Medical Technology Association, announced the election of several new members to its board of directors. The new board members are: Gregory Arnsdorff, VP of Abbott Laboratories and president of Abbott Point of Care; Nefertiti Greene, VP of US diabetes care at Bayer HealthCare Diabetes Care; Brian Miller, managing partner at Linden Capital Partners; and Rick Brajer, president and CEO of LipoScience.


AssureRx Health has appointed Stephen Stamp as its senior VP and CFO and Jeffrey Bush as if VP of payor markets and reimbursement. Stamp comes to AssureRx from EZCorp, where he was CFO. Bush joins AssureRx from Becton, Dickinson and Company, where he served as senior director of reimbursement strategy and payment policy.

According to the AssureRx, the new appointments come as demand for its GeneSight pharmacogenomic testing service is increasing.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.